Papillary thyroid cancer and polymorphic variants in TSHR- and RET-related genes: A nested case-control study within a cohort of U.S. radiologic technologists

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 1, 2007, Pages 174-177

  Lönn, Stefan ^a   Bhatti, Parveen ^a   Alexander, Bruce H ^b   Pineda, Marbin A ^a   Doody, Michele M ^a   Struewing, Jeffery P ^a   Sigurdson, Alice J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN RET; THYROTROPIN RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC IMMUNIZATION; GENETIC POLYMORPHISM; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; RADIOLOGICAL TECHNOLOGIST; THYROID CANCER; UNITED STATES;

ADULT; AGED; CARCINOMA, PAPILLARY; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROTO-ONCOGENE PROTEINS C-RET; RECEPTORS, THYROTROPIN; THYROID NEOPLASMS;

EID: 33846572959     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0665     Document Type: Article

References (19)

1. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006;295:2164-7.
2. Burgess JR. Temporal trends for thyroid carcinoma in Australia: an increasing incidence of papillary thyroid carcinoma (1982-1997). Thyroid 2002;12:141-9.
3. Howe HL, Wingo PA, Thun MJ, et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 2001;93:824-42.
4. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29.
5. Ron E. Thyroid Cancer. In: Schottenfeld D, Fraumeni JF, editors. Cancer epidemiology and prevention. 2nd ed. Oxford and New York: Oxford University Press; 1996.
6. Franceschi S, Preston-Martin S, Dal Maso L, et al. A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases. Cancer Causes Control 1999;10:583-95.
7. Preston-Martin S, Franceschi S, Ron E, Negri E. Thyroid cancer pooled analysis from 14 case-control studies: what have we learned? Cancer Causes Control 2003;14:787-9.
8. Inskip PD. Thyroid cancer after radiotherapy for childhood cancer. Med Pediatr Oncol 2001;36:568-73.
9. Kondo T, Ezzat S, Asa SL. Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 2006;6:292-306.
10. Hoffmann S, Hofbauer LC, Scharrenbach V, et al. Thyrotropin (TSH)-induced production of vascular endothelial growth factor in thyroid cancer cells in vitro: evaluation of TSH signal transduction and of angiogenesis-stimulating growth factors. J Clin Endocrinol Metab 2004;89:6139-45.
11. Eng C. RET proto-oncogene in the development of human cancer. J Clin Oncol 1999;17:380-93.
12. Ho T, Li G, Zhao C, Wei Q, Sturgis EM. RET polymorphisms and haplotypes and risk of differentiated thyroid cancer. Laryngoscope 2005;115: 1035-41.
13. Fagin JA. Molecular genetics of human thyroid neoplasms. Annu Rev Med 1994;45:45-52.
14. Sigurdson AJ, Doody MM, Rao RS, et al. Cancer incidence in the U.S. Radiologic Technologists Health Study, 1983-1998. Cancer 2003;97:3080-9.
15. Stredrick DL, Garcia-Closas M, Pineda MA, et al. The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer. Hum Mutat 2006;6:538-44.
16. Sigurdson AJ, Hauptmann M, Chatterjee N, et al. Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes. BMC Cancer 2004;4:9.
17. Lesueur F, Corbex M, McKay JD, Lima J, Soares P, Griseri P. Specific haplotypes of the RET proto-oncogene are over-represented in patients with sporadic papillary thyroid carcinoma. J Med Genet 2002;39:260-5.
18. Cebrian A, Lesueur F, Martin S, et al. Polymorphisms in the initiators of RET (rearranged during transfection) signaling pathway and susceptibility to sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 2005;90:6268-74.
19. Bhatti P, Sigurdson AJ, Wang SS. Genetic variation and willingness to participate in epidemiologic research: data from three studies. Cancer Epidemiol Biomarkers Prev 2005;14:2449-53.